CIK 0001368514
- Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 562590442
- Phone
- +1 201-478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- 4 Grant or award Director acquired 25,815 shares (grant or award)
- 4 Shares withheld for taxes President and CEO gave up 166,867 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, CFO gave up 114,222 shares (to pay taxes)
- 4 Open-market buy EVP, CFO bought 6,993 shares at $2.86 ($20,000)
- 4 Open-market buy President and CEO bought 29,965 shares at $2.86 ($85,700)
- 4 Shares withheld for taxes President and CEO gave up 101,315 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, CFO gave up 73,678 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, CFO gave up 51,965 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 70,004 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, CFO gave up 37,178 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 50,539 shares (to pay taxes)
- 4 Grant or award Director acquired 26,586 shares (grant or award)
- 4 Grant or award Director acquired 26,586 shares (grant or award)
- 4 Grant or award Director acquired 26,586 shares (grant or award)
- 4 Grant or award Director acquired 26,586 shares (grant or award)
- 4 Grant or award EVP, CFO acquired 137,500 shares (grant or award)
- 4 Grant or award Director acquired 26,586 shares (grant or award)
- 4 Grant or award President and CEO acquired 300,000 shares (grant or award)
- 4 Grant or award Director acquired 26,586 shares (grant or award)
- 4 Open-market buy Director bought 100,000 shares at $1.00 ($100,000)
Page 7 of 19 · 362 filings